InvestorsHub Logo
Followers 62
Posts 7549
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Thursday, 04/13/2023 12:08:30 PM

Thursday, April 13, 2023 12:08:30 PM

Post# of 425923
Amarin has partnered with Eddingpharm since 2015 with no China approval of Vascepa as yet for the mainland....Perhaps its time for Amarin to look elsewhere....

PFE: Pfizer collaborates with Sinopharm to expand in China

From: SA Breaking News @seekingalpha.com>
Date: Thu, Apr 13, 2023 at 11:18?AM
"Pfizer collaborates with Sinopharm to expand in China

Pfizer (NYSE:PFE) announced Thursday a strategic corporation agreement with Shanghai-based Sinopharm Group (OTCPK:SHTDF) (OTCPK:SHTDY) to expand its market presence in China.
Per the terms, the two companies will join hands to seek approval to market as many as 12 innovative drugs in China through 2025, Reuters reported citing a statement from New York-based Pfizer (PFE).
At the launch of the partnership in Shanghai, Sinopharm (OTCPK:SHTDF) president Liu Yong said that the collaboration aims to speed up the deployment of Pfizer’s (PFE) new treatments to patients.
Rival Merck (MRK) has a partnership with Sinopharm (OTCPK:SHTDF) to commercialize the oral COVID pill, molnupiravir, in China, while Pfizer (PFE) has joined hands with local drug maker Zhejiang Huahai to manufacture its oral therapy Paxlovid in the country."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News